Literature DB >> 19911072

Successful treatment of a brain-metastasized renal cell carcinoma.

M Sami Walid1, Kim W Johnston.   

Abstract

Renal cell carcinoma is an uncommon type of cancer that rarely metastasizes to the brain. The prognosis after discovering brain metastasis has traditionally been dismal. We are presenting a case of renal cell carcinoma with multiple brain metastases that was successfully treated with multimodal therapy including a new type of medication.

Entities:  

Keywords:  brain metastasis; renal cell carcinoma; sorafenib

Mesh：

Substances：

Year:  2009        PMID： 19911072      PMCID： PMC2775194          DOI： 10.3205/000087

Source DB:  PubMed          Journal:  Ger Med Sci        ISSN： 1612-3174


  5 in total

Review 1.  Renal-cell carcinoma.

Authors:  Herbert T Cohen; Francis J McGovern
Journal:  N Engl J Med       Date:  2005-12-08       Impact factor: 91.245

2.  Brain metastasis from renal cell carcinoma: presentation, recurrence, and survival.

Authors:  Brian Shuch; Jeff C La Rochelle; Tobias Klatte; Stephen B Riggs; Weiqing Liu; Fairooz F Kabbinavar; Allan J Pantuck; Arie S Belldegrun
Journal:  Cancer       Date:  2008-10-01       Impact factor: 6.860

3.  Brain metastasis in renal cell cancer responding to sunitinib.

Authors:  Angelos K Koutras; Dimitrios Krikelis; Natassa Alexandrou; Ioannis Starakis; Haralabos P Kalofonos
Journal:  Anticancer Res       Date:  2007 Nov-Dec       Impact factor: 2.480

Review 4.  Role of sunitinib and sorafenib in the treatment of metastatic renal cell carcinoma.

Authors:  Jon J Hiles; Jill M Kolesar
Journal:  Am J Health Syst Pharm       Date:  2008-01-15       Impact factor: 2.637

5.  Long-lasting successful cerebral response with sorafenib in advanced renal cell carcinoma.

Authors:  Francesca Valcamonico; Vittorio Ferrari; Vito Amoroso; Giovanni Rangoni; Edda Simoncini; Patrizia Marpicati; Lucia Vassalli; Salvatore Grisanti; Giovanni Marini
Journal:  J Neurooncol       Date:  2008-08-19       Impact factor: 4.130
  5 in total
  6 in total

1.  Impact of tyrosine kinase inhibitors on the incidence of brain metastasis in metastatic renal cell carcinoma.

Authors:  Jonathan Verma; Eric Jonasch; Pamela Allen; Nizar Tannir; Anita Mahajan
Journal:  Cancer       Date:  2011-04-11       Impact factor: 6.860

2.  The impact of tyrosine kinase inhibitors on the multimodality treatment of brain metastases from renal cell carcinoma.

Authors:  Jonathan Verma; Eric Jonasch; Pamela K Allen; Jeffrey S Weinberg; Nizar Tannir; Eric L Chang; Anita Mahajan
Journal:  Am J Clin Oncol       Date:  2013-12       Impact factor: 2.339

Review 3.  Oral Targeted Therapies and Central Nervous System (CNS) Metastases.

Authors:  Michael P Gabay; Scott M Wirth; Joan M Stachnik; Colleen L Overley; Katie E Long; Linda R Bressler; John L Villano
Journal:  CNS Drugs       Date:  2015-11       Impact factor: 5.749

4.  Chronic headache as the first symptom of an undiagnosed renal cell carcinoma.

Authors:  Mohammad Kazem Moslemi; Mehdi Abedinzadeh
Journal:  Case Rep Oncol       Date:  2011-12-07

5.  Resveratrol attenuates constitutive STAT3 and STAT5 activation through induction of PTPε and SHP-2 tyrosine phosphatases and potentiates sorafenib-induced apoptosis in renal cell carcinoma.

Authors:  Chulwon Kim; Sang Hyun Baek; Jae-Young Um; Bum Sang Shim; Kwang Seok Ahn
Journal:  BMC Nephrol       Date:  2016-02-25       Impact factor: 2.388

6.  Innovative therapeutic strategies in the treatment of brain metastases.

Authors:  Maria Caffo; Valeria Barresi; Gerardo Caruso; Mariano Cutugno; Giuseppe La Fata; Mario Venza; Concetta Alafaci; Francesco Tomasello
Journal:  Int J Mol Sci       Date:  2013-01-22       Impact factor: 5.923
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.